Surgical Site Infection Control Market Share

Surgical Site Infection Control Market Overview

Surgical Site Infection Control Market Size was valued at USD 5.04 Billion in 2023. The Surgical Site Infection Control industry is projected to grow from USD 5.33 Billion in 2024 to USD 8.47 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.95% during the forecast period (2024 - 2032).

A surgical site infection occurs after surgery in any part of the body where the surgery took place. Surgical site infections can sometimes be superficial infections involving the skin only. Other surgical site infections are more serious and can involve tissues under the skin, organs, or implanted material.

Factors such as increasing cost of healthcare and mounting prevalence of certain fatal diseases including cancer, coronary heart diseases, etc., also increasing geriatric population are driving the growth of the surgical site infection control market. Other factors such as the rising number of surgeries, increase in hospital-acquired infection, and rapidly increasing geriatric population are fueling the market growth. However, the rise in use of outpatient treatment and lack of awareness of hospital infection prevention and control are hampering the market growth.

In October 2023, Sylke Inc introduced SYLKE™, the inaugural dressing composed entirely of hypoallergenic silk fibroin. SYLKE™ is specifically engineered to improve the healing process of surgical wounds and minimize the occurrence of problems and infections, ultimately resulting in better scarring outcomes.

In October 2021, Healthium Medtech Limited introduced TRUSHIELD NXT surgical wound dressing, expanding its collection of patented products in the fields of wound care and infection control. Healthium's product range encompasses advanced surgery, urology, and arthroscopy items, in addition to wound care.

Surgical Site Infection Control Market Segment Insights

The Surgical Site Infection Control Market is segmented based on product, procedure, type of infection, end user, and region.

On the basis of product, the market is segmented into Manual Reprocessors Solution, Disinfectants, Surgical Scrubs, Surgical Drapes, Skin Preparation Solution, Medical Nonwovens, Surgical Gloves, and Others. The Disinfectants is segmented into hand disinfectants and skin disinfectants.

On the basis of procedure, the market is segmented into cataract surgery, cesarean section, dental restoration, gastric bypass, and others.

On the type of infection, the market is segmented into Superficial Incisional SSI, Deep Incisional SSI

Organ or Space SSI.

On the basis of End User, the market is segmented into hospitals and ambulatory surgical centers.

The Americas dominated the global market of surgical site infection control. Increasing healthcare expenditure, rising incidence of chronic diseases, increasing awareness regarding healthcare management, and growing geriatric population are some other factors expected to drive the growth of the Americas surgical site infection control market.

In 2017, it was estimated that Europe stood second in the global healthcare information systems market. This can be attributed due to the increasing awareness regarding hygiene and sanitation, government support for ensuring high degree infection prevention, formulation of various awareness programs by NGO and Government, development of technologically advanced medical products, and growing number of surgical site infection cases are some other factors expected to drive growth of the target market over the forecasted period. However, strict regulation is the factors expected to hamper the growth of the Market over the forecast period.

Asia-Pacific was the fastest growing region for the Surgical Site Infection Control Market in 2017. Asia-Pacific has a huge market potential for the Healthcare IT industry. India and China are some of the rapidly growing countries, followed by South Korea. Consequently, the government in these rapidly developing economies have taken various efforts to improve healthcare services and provide better infrastructure.

On the other hand, the Middle East and Africa held the least share in the Surgical Site Infection Control Market. Presence of poor economies and low per capita income, especially within the African region make the market to lag within the region. Most of the market share within this region is estimated to be held by the Middle East due to increasing government funding in the healthcare, and presence of developed economies such as the UAE, Kuwait, Dubai, and others.

Research Methodology

Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.

• Primary Research

Extensive primary research was conducted to gain a deeper insight into the market and industry performance. In this particular report, we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.

• Secondary Research

Secondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and commercial study of the Surgical Site Infection Control Market. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.

Intended Audience

• Pharmaceutical companies


• Government and private laboratories


• Research and Development (R&D) companies


• Market research and consulting service providers

Surgical Site Infection Control Market Segmentation

Surgical Site Infection Control Product Outlook

• Manual Reprocessors Solution
  
  
  
  • Disinfectants
  
  
  • Hand Disinfectants
  
  
  
  


• Skin Disinfectants


• Surgical Scrubs


• Surgical Drapes


• Skin Preparation Solution


• Medical Nonwovens


• Surgical Gloves


• Others

Surgical Site Infection Control Procedure Outlook

• Cataract Surgery


• Cesarean Section


• Dental Restoration


• Gastric Bypass


• Others

Surgical Site Infection Control Type of Infection Outlook

• Superficial Incisional SSI


• Deep Incisional SSI


• Organ or Space SSI

Surgical Site Infection Control End User Outlook

• Hospitals


• Ambulatory Surgical Centers

Key Players

• 3M


• Becton Dickinson and Company


• Belimed AG


• bioMerieux SA


• Getinge Group


• Johnson & Johnson


• Kimberly-Clark Corporation


• Sotera Health


• Ansell Limited


• Steris Corporation


• Lac-Mac Limited


• Pacon Manufacturing Corp


• American Polyfilm Inc.


• Others